Doctor profile · Federal record
Dr. Cassandra Rullman, PA-C
Physician Assistant · Physician Assistant · Chevy Chase, MD
- NPI 1649746801
- Accepts Medicare
- 7 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5530 Wisconsin Ave Ste 1418
Chevy Chase, MD 208154302
(301) 986-1880
fax (301) 718-7372 - Mailing address
-
108 Stone Point Dr Unit 324
Annapolis, MD 214016992
Credentials & registration
- NPI registered
- October 2018 — 8 yrs on file
- Profile last updated
- May 25, 2023
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State licenses (2)
- Maryland #C0008820 · Georgia #9454
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1649746801. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,804
Distinct HCPCS
10
Medicare allowed
$109,066
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 594 | 123 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 346 | 247 | $86 | |
17000 |
Destruction of precancer skin growth, 1 growth | 192 | 168 | $48 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 131 | 115 | $122 | |
11102 |
Biopsy of related skin growth, first growth | 130 | 115 | $81 | |
17110 |
Destruction of skin growth, 1-14 growths | 128 | 106 | $109 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 52 | 17 | $1 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 48 | 41 | $168 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 45 | 45 | $108 | |
11103 |
Biopsy of related skin growth, each additional growth | 36 | 24 | $50 |
In context: peer comparison
Among 7 peers in Chevy Chase Physician Assistant, average services per provider: 74. This provider delivers 24× the peer median.Open Payments
Industry payments received
All-time total
$706
Transactions
18
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Revance Therapeutics, INC. | 3 | $217.34 | |
| Regeneron Healthcare Solutions, INC. | 1 | $124.94 | |
| Genzyme Corporation | 3 | $120.70 | |
| Sun Pharmaceutical Industries INC. | 2 | $48.88 | |
| Amgen INC. | 2 | $48.19 | |
| Galderma Laboratories, L.P. | 2 | $31.49 | |
| Incyte Corporation | 1 | $28.97 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $24.06 | |
| Novartis Pharmaceuticals Corporation | 1 | $22.48 | |
| Arcutis Biotherapeutics, INC. | 1 | $19.81 | |
| Abbvie INC. | 1 | $18.91 |
By nature of payment
Frequently asked questions
What is Dr. Cassandra Rullman's medical specialty?
Dr. Cassandra Rullman practices Physician Assistant in Chevy Chase, MD.
Where does Dr. Cassandra Rullman practice?
Dr. Cassandra Rullman practices at 5530 Wisconsin Ave Ste 1418, Chevy Chase, MD 208154302. Office phone: 3019861880.
What is Dr. Cassandra Rullman's NPI?
Dr. Cassandra Rullman's National Provider Identifier (NPI) is 1649746801, issued by NPPES.
Does Dr. Cassandra Rullman accept Medicare assignment?
Yes. Dr. Cassandra Rullman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Cassandra Rullman commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.